Heart Disease News and Research

Latest Heart Disease News and Research

Physician's choice of words play important role in determining critical end-of-life decisions

A physician's choice of words when talking with family members about whether or not to try cardiopulmonary resuscitation if a critically ill patient's heart stops may influence the decision, according to a study by University of Pittsburgh researchers in the June edition of Critical Care Medicine and now available online.

10 May 2013

AACN to present Marguerite Rodgers Kinney Award for a Distinguished Career to MGH's Sally Millar

The American Association of Critical-Care Nurses will present the Marguerite Rodgers Kinney Award for a Distinguished Career to Sally Millar, RN, MBA. She will receive this Visionary Leadership Award for contributions to AACN's mission and vision at the 2013 National Teaching Institute & Critical Care Exposition, Boston, May 18-23.

10 May 2013

Insomnia and altered sleep duration may increase risk of CHD and CVD during menopause

Insomnia and other sleep disturbances are common among perimenopausal and postmenopausal women and may increase their risk of coronary heart disease (CHD) and cardiovascular disease (CVD).

10 May 2013

Loyola and Edward Hines receive award to study MBSR in women veterans at risk for heart disease

Loyola University Chicago Marcella Niehoff School of Nursing researchers and Edward Hines, Jr. VA Hospital recently were given an award to study mindfulness-based stress reduction (MBSR) in women veterans at risk for heart disease.

9 May 2013

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

In cancer, mutations in proteins that control cell growth are common, leading to unrestrained cellular proliferation and tumor formation.

9 May 2013

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

When Alfred Williams was admitted to Ochsner Medical Center in December, the 41-year-old father of five had exhausted all treatment options for his enlarged heart. His condition, known as dilated cardiomyopathy, had progressed to end-stage heart failure affecting both sides of his heart. Unable to walk, he had been confined to a bed for months. Hospice care seemed like the only option Mr. Williams had left… until doctors approached him about becoming Ochsner's first patient to receive the SynCardia temporary Total Artificial Heart.

9 May 2013

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

FirstMark, a division of GenWay Biotech that is focused on developing and commercializing noninvasive diagnostic and health monitoring tests for unmet clinical needs, today announced that results from the break-through proof-of-concept clinical study, performed in collaboration with Emory University and MedStar Washington Hospital Center, will be published in the Journal of the American College of Cardiology.

9 May 2013

Abbott receives CE Mark for ARCHITECT HbA1c test

Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.

9 May 2013

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Trevena, Inc., a clinical stage pharmaceutical company and the leader in the discovery and development of G-protein coupled receptor biased ligands, and Forest Laboratories Holding Limited, a subsidiary of Forest Laboratories Inc., an international pharmaceutical company, announced today that they have entered into a collaborative licensing option agreement for the development of TRV027, an AT1R biased-ligand that recently completed Phase 2a clinical trials.

9 May 2013

Researchers discover that microRNAs link two defining characteristics of fit muscles

Researchers discovered that small pieces of genetic material called microRNAs link the two defining characteristics of fit muscles: the ability to burn sugar and fat and the ability to switch between slow- and fast-twitch muscle fibers.

9 May 2013

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

More than 100,000 Geisinger Health System patients will have access to their doctors' notes for the first time through the secure MyGeisinger online patient portal when Geisinger expands OpenNotes in May due to the initiative's overwhelming success.

9 May 2013

UA researchers discover genetic mutations that cause severe epilepsies in children

Researchers at the University of Arizona have successfully determined the genetic mutations causing severe epilepsies in seven out of 10 children for whom the cause of the disorder could not be determined clinically or by conventional genetic testing.

9 May 2013

Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published

Charles H. Hennekens, M.D., Dr.P.H., the first Sir Richard Doll professor and senior academic advisor to the dean in the Charles E. Schmidt College of Medicine at Florida Atlantic University published a review for clinicians on the optimal utilization of aspirin to treat and prevent heart attacks.

9 May 2013

Study suggests new application for endovascular grafts

Tumors have the potential to grow locally and invade neighboring organs. Some chest tumors may invade one of the great vessels of the body, the aorta. Surgical removal of these tumors is very challenging and necessitates the support of a heart-lung machine.

9 May 2013

Gene offers new insights into treatment strategies for deep-vein thrombosis

A gene associated with both protection against bacterial infection and excessive blood clotting could offer new insights into treatment strategies for deep-vein thrombosis -- the formation of a harmful clot in a deep vein.

9 May 2013

Researchers find that whole walnuts and their oil components can improve heart health

Consumption of whole walnuts or their extracted oil can reduce cardiovascular risk through a mechanism other than simply lowering cholesterol, according to a team of Penn State, Tufts University and University of Pennsylvania researchers.

9 May 2013

New therapeutic targets for reducing heart disease in people with type 1 diabetes

Type 1 (insulin-dependent) diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating the production of calprotectin, a protein that sparks an inflammatory process that fuels the buildup of artery-clogging plaque.

8 May 2013

HSPH researchers discover potential target to treat type 2 diabetes and other metabolic diseases

Harvard School of Public Health (HSPH) researchers have discovered that a particular type of protein (hormone) found in fat cells helps regulate how glucose (blood sugar) is controlled and metabolized (used for energy) in the liver.

8 May 2013

Study shows patient selection based on biosamples makes clinical trials more efficient, reduces costs

Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial size, saves money, and may speed test drugs through the drug development pipeline.

8 May 2013

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it has received approval from the Food and Drug Administration to initiate patient enrollment in the EXCELLA III clinical trial in the United States at up to 50 institutions with conditions to be addressed in parallel.

8 May 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Physician's choice of words play important role in determining critical end-of-life decisions

AACN to present Marguerite Rodgers Kinney Award for a Distinguished Career to MGH's Sally Millar

Insomnia and altered sleep duration may increase risk of CHD and CVD during menopause

Loyola and Edward Hines receive award to study MBSR in women veterans at risk for heart disease

Drug resistant brain tumors: an interview with Prof. Mischel, Ludwig Institute for Cancer Research and Prof. Bensinger, University of California

Ochsner Medical Center performs Gulf South Region's first implant of SynCardia Total Artificial Heart

Clinical study predicting risk of near-term MI and death in CAD patients to be published in JACC

Abbott receives CE Mark for ARCHITECT HbA1c test

Trevena, Forest sign collaborative agreement to develop TRV027 for treatment of ADHF

Researchers discover that microRNAs link two defining characteristics of fit muscles

GHS patients to have access to doctors' notes through MyGeisinger online patient portal

UA researchers discover genetic mutations that cause severe epilepsies in children

Review for clinicians on optimal utilization of aspirin to treat, prevent heart attacks published

Study suggests new application for endovascular grafts

Gene offers new insights into treatment strategies for deep-vein thrombosis

Researchers find that whole walnuts and their oil components can improve heart health

New therapeutic targets for reducing heart disease in people with type 1 diabetes

HSPH researchers discover potential target to treat type 2 diabetes and other metabolic diseases

Study shows patient selection based on biosamples makes clinical trials more efficient, reduces costs

Elixir Medical receives FDA approval to initiate patient enrollment in EXCELLA III clinical trial in US

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in